cherryjackpotcasinonodepositbonus|葵花药业：复方聚乙二醇（3350）电解质散获得上市许可受理

News summary

sunflower pharmaceuticalcherryjackpotcasinonodepositbonus: Compound Polyethylene Glycol (3350) Electrolyte Powder was accepted for marketing approval. Securities Times Company e News, Sunflower Pharmaceutical (002737) announced on the evening of May 5 that its wholly-owned subsidiary Harbin Sunflower Pharmaceutical Co., Ltd.(referred to as "Harbin Sunflower") Recently received a receipt from the State Drug Administrationcherryjackpotcasinonodepositbonus.cherryjackpotcasinonodepositbonus..

Newsletter text

sunflower pharmaceuticalcherryjackpotcasinonodepositbonus: Compound Polyethylene Glycol (3350) Electrolyte Powder was accepted for marketing authorization Securities Times Company e News, Sunflower Pharmaceutical (002737) announced on the evening of May 5 that its wholly-owned subsidiary Harbin Sunflower Pharmaceutical Co., Ltd.(referred to as "Harbin Sunflower") Recently received the "Acceptance Notice" issued by the State Food and Drug Administration on the application for registration and marketing authorization of Compound Polyethylene Glycol (3350) Electrolyte Powder, and proposed the indications (or functional indications): Used to treat chronic constipation in children aged 1 to 11 years and fecal impaction in children aged 5 to 11 years.